Form 4: ClearPoint Neuro Director Trades CLPT Stock

ClearPoint Neuro, Inc. director Timothy T. Richards reported transactions involving the acquisition and disposition of company stock.

Summary

• Timothy T. Richards, a Director at ClearPoint Neuro, Inc., engaged in stock transactions on June 4, 2026.
• Richards acquired 500 shares of common stock at a price of $10 per share.
• He also disposed of 376 shares of common stock at a price of $13.30 per share.
• Following these transactions, Richards beneficially owns 87,322 shares of common stock.
• The filing also notes a stock option for 500 shares at an exercise price of $10, which was previously adjusted for a stock split.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions with both acquisitions and dispositions, offering no strong indication of significant positive or negative sentiment.

Positives

• Director Timothy T. Richards acquired shares, indicating a potential belief in the company's value.
• The acquisition of 500 shares at $10 per share suggests a strategic purchase by a key insider.

Negatives

• Director Timothy T. Richards disposed of 376 shares at $13.30 per share, potentially indicating a partial divestment.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which primarily reports past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the buying and selling activities of company directors and officers. These transactions can offer insights into management's confidence in the company's prospects.

Stakeholder Impact

• Shareholders may interpret the acquisition of shares by a director as a positive signal of confidence in the company's future performance.
• Conversely, the disposition of shares by a director could be viewed with caution, though the net beneficial ownership remains substantial.

Key Dates

Keywords

ClearPoint Neuro, CLPT, Form 4, Insider Trading, Stock Transaction, Director, Beneficial Ownership, Stock Options